Wolters Kluwer N.V. · EURONEXT:WKL

Wolters Kluwer — FY2015 Earnings Presentation

45 slides from Wolters Kluwer's earnings presentation, Feb 24, 2016

  1. Slide 1: Wolters Kluwer 2015 Full-Year Results

    Wolters Kluwer 2015 Full-Year Results Nancy McKinstry – CEO Kevin Entricken – CFO February 24, 2016

  2. Slide 2: Forward-looking Statements

    Forward-looking Statements This presentation contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall", and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncerta

  3. Slide 3: Agenda

    Agenda  Introduction  Financial Review  Strategic and Operating Review  Outlook 2016  Appendix 2015 Full-Year Results 3

  4. Slide 4: Introduction

    Introduction Strategy is delivering improved performance  Organic growth improved to +3% – Digital & services revenues grew +5% organically (83% of total revenues)  Met or exceeded guidance – Adjusted operating profit margin increased in line with guidance – Adjusted free cash flow up +7% in const

  5. Slide 5: Strategic progress

    Strategic progress Key achievements 2015 ▪ Delivered 7% organic growth in leading, growth positions Expand ▪ Acquired Learner’s Digest International in Health and our leading, smaller bolt-on assets in Tax & Accounting high growth ▪ Divested Russia and several non-core assets positions ▪ Sustained i

  6. Slide 6: Agenda

    Agenda  Introduction  Financial Review  Strategic and Operating Review  Outlook 2016  Appendix 2015 Full-Year Results 6

  7. Slide 7: Full-year 2015 results

    Full-year 2015 results Organic growth accelerated, operating margin and ROIC improved (€ million, unless otherwise stated) FY 2015 FY 2014 ∆ ∆ CC ∆ OG Revenues 4,208 3,660 +15% +3% +3% Adjusted operating profit 902 768 +17% +2% +3% Adjusted operating profit margin 21.4% 21.0% Diluted adjusted EPS €1

  8. Slide 8: Revenues – new divisions

    Revenues – new divisions Organic growth in Health, Tax & Accounting, and Governance, Risk & Compliance more than offset decline in Legal & Regulatory (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG Health 1,022 816 +25% +6% +5% Tax & Accounting 1,132 989 +14% +4% +3% Governance, Risk & Compliance 1,065 854

  9. Slide 9: Revenues – previous divisions

    Revenues – previous divisions Tax & Accounting, Health and Financial & Compliance Services drive growth (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG Legal & Regulatory 1,626 1,497 +9% 0% 0% Tax & Accounting 1,078 946 +14% +3% +3% Health 1,022 816 +25% +6% +5% Financial & Compliance Services 482 401 +20%

  10. Slide 10: Revenues by region

    Revenues by region Organic growth continues to be driven by North America and Asia Pacific & ROW (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG North America 2,509 1,999 +26% +5% +5% Europe 1,371 1,373 0% -1% -1% AsiaPac & ROW 328 288 +14% +4% +4% Total revenues 4,208 3,660 +15% +3% +3% ∆: % Change; ∆ CC:

  11. Slide 11: Revenues by media format

    Revenues by media format Digital revenues sustained 6% organic growth (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG Digital 2,962 2,472 +20% +7% +6% Services 523 453 +16% 0% +3% Print 723 735 -1% -9% -7% Total revenues 4,208 3,660 +15% +3% +3% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33)

  12. Slide 12: Adjusted operating profit – new divisions

    Adjusted operating profit – new divisions Margin increases in Tax & Accounting and Governance, Risk & Compliance more than offset expected decline in Legal & Regulatory margin Margin Margin (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG FY 2015 FY 2014 Health 247 197 +25% +5% +4% 24.1% 24.1% Tax & Accounti

  13. Slide 13: Adjusted operating profit – previous divisions

    Adjusted operating profit – previous divisions Financial & Compliance Services was a key contributor to the margin increase Margin Margin (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG FY 2015 FY 2014 Legal & Regulatory 320 305 +5% -8% -7% 19.7% 20.3% Tax & Accounting 295 250 +18% +6% +7% 27.4% 26.4% Healt

  14. Slide 14: Adjusted net profit and EPS

    Adjusted net profit and EPS Diluted adjusted EPS up +5% in constant currencies (€ million, unless otherwise stated) FY 2015 FY 2014 ∆ ∆ CC Revenues 4,208 3,660 +15% +3% Adjusted operating profit 902 768 +17% +2% Adjusted operating profit margin 21.4% 21.0% Adjusted net financing costs (119) (113) Eq

  15. Slide 15: IFRS profit and diluted EPS

    IFRS profit and diluted EPS Reported EPS declines 10%, reflecting one-off factors related to tax (€ million, unless otherwise stated) FY 2015 FY 2014 ∆ Adjusted operating profit 902 768 +17% Amortization of acquired intangibles (214) (192) Results on divestments of operations (14) 10 Acquisition int

  16. Slide 16: Adjusted free cash flow

    Adjusted free cash flow Cash conversion of 100%, better than expected (€ million, unless otherwise stated) FY 2015 FY 2014 ∆ ∆ CC Adjusted operating profit 902 768 +17% +2% Depreciation and amortization of other intangibles 171 140 Adjusted EBITDA 1,073 908 +18% +3% Capital expenditure (188) (148) A

  17. Slide 17: Movement in net debt

    Movement in net debt Leverage ratio improved to 1.7x, despite over 55% of free cash flow returned to shareholders (€ million, unless otherwise stated) FY 2015 FY 2014 Net debt at January 1 (1,897) (1,988) Adjusted free cash flow, incl. Springboard 647 512 Dividends paid (263) (209) Acquisition spend

  18. Slide 18: Leverage

    Leverage Net-debt-to-EBITDA improved to 1.7x, better than target level Net-Debt-to-EBITDA (Ratio) 3.1x Target: 2.7x 2.5x 2.4x 2.2x 2.1x 1.7x 2010 2011 2012 2013 2014 2015 2015 Full-Year Results 18

  19. Slide 19: Dividend

    Dividend Proposing full-year total dividend of €0.75 per share, up +6% Dividend per Share (€)1)  2015: introduced semi-annual dividend frequency. Interim dividend of €0.18 0.75 paid in October 2015 0.67 0.68 0.69 0.70 0.71 0.64 0.65 0.66 0.58 Proposed  Proposing final dividend of €0.57, 0.55 final

  20. Slide 20: Share buybacks

    Share buybacks Completed €140 million share buyback in 2015. Announcing up to €600 million buyback over the next three years (2016-2018) Share Buybacks (€ million)  Committed to anti-dilution policy to offset dilution caused by performance share issuance Share Buyback  Announcing intention to buy

  21. Slide 21: Summary

    Summary  Organic growth accelerated to +3%  Adjusted operating margin 21.4%, increased by 40 basis points  Diluted adjusted EPS €1.96, up +5% in constant currencies  Adjusted free cash flow of €647 million, up +7% in constant currencies  Net-debt-to-EBITDA ratio improved to 1.7x  Proposing ful

  22. Slide 22: Agenda

    Agenda  Introduction  Financial Review  Strategic and Operating Review  Outlook 2016  Appendix 2015 Full-Year Results 22

  23. Slide 23: Health

    Health Sustained +5% organic growth; margin reflects increased investment and restructuring € million FY 2015 FY 2014 Δ Δ CC Δ OG Clinical Solutions Revenues 1,022 816 +25% +6% +5%  Organic growth +10%, driven by double- digit growth of UpToDate Adjusted operating profit 247 197 +25% +5% +4%  Drug

  24. Slide 24: Tax & Accounting

    Tax & Accounting Organic growth +3% supported by software +6%; margins improved € million FY 2015 FY 2014 Δ Δ CC Δ OG North America Revenues 1,132 989 +14% +4% +3%  Good organic growth driven by software and other digital products Adjusted operating profit 311 261 +19% +7% +8%  Cloud-based suite,

  25. Slide 25: Governance, Risk & Compliance

    Governance, Risk & Compliance Organic growth +5%, buoyed by non-recurring revenues; margins improved € million FY 2015 FY 2014 Δ Δ CC Δ OG Corporate Legal Services Revenues 1,065 854 +25% +7% +5%  Organic growth +6%, including +2% in 4Q  CLS transactional revenues +8% Adjusted operating profit 298

  26. Slide 26: Legal & Regulatory

    Legal & Regulatory Organic decline as print still outweighs digital growth; margins impacted by planned increase in restructuring € million FY 2015 FY 2014 Δ Δ CC Δ OG Legal & Regulatory Revenues 989 1,001 -1% -5% -2%  Organic growth -2%, improving modestly (2014: -3%) Adjusted operating profit 96

  27. Slide 27: Strategy 2013-2015

    Strategy 2013-2015 Our strategy of the past few years has driven continued portfolio transformation Revenues by Media Format Revenues by Type Revenues by Geographic Market 9% 7% 17% 26% 17% 33% 17% 40% 13% 13% 8% 6% 74% 76% 70% 61% 54% 59% 2012 2015 2012 2015 2012 2015 Digital Recurring Europe Servi

  28. Slide 28: Strategy 2013-2015

    Strategy 2013-2015 Leading, high growth units, now 51% of total revenues, grew +7% organically % of 2015 divisional Organic Growth revenues Leading High Growth Units Divisions:1) 2012 2015 Finance, Risk & F&CS 49% 58% Compliance; Audit +7% Total Clinical Health 38% 47% +10% Leading Solutions High Gr

  29. Slide 29: Organic growth and margin

    Organic growth and margin Organic growth accelerated and margin improved Organic Growth (%) Adjusted Operating Profit Margin (%) 6% 6% Digital revenues 5% 5% 4% 4% 21.7% 21.5% 21.5% 21.4% 3% 21.0% 2% 2% 20.4% 19.9% 1% 1% 1% 0% Total Wolters Kluwer -3% 2009 2010 2011 2012 2013 2014 2015 2009 2010 201

  30. Slide 30: Market trends

    Market trends Changing customer needs are creating opportunities and challenges 1 Continued 2 Increasing 3 4 Changing 5 Increasing pressure on volume and High growth of client needs: disruption from professionals to complexity of professionals in millennials work cloud, mobile, improve global develo

  31. Slide 31: Strategic priorities 2016-2018

    Strategic priorities 2016-2018 Our plan for 2016-2018 builds on the strategic direction of the past three years ▪ Allocate majority of capital to leading, growing businesses Expand ▪ Extend into adjacent market segments and new geographies ▪ Broaden our global sales and marketing coverage Market Cov

  32. Slide 32: Product innovation

    Product innovation Continued investment in Expert Solutions and other digital innovation UpToDate Cheetah Clinical decision support resource for New intuitive legal research platform healthcare practitioners 2015 2015  Double-digit organic growth; reached 1.1 million  Greatly enhanced usability, s

  33. Slide 33: Agenda

    Agenda  Introduction  Financial Review  Strategic and Operating Review  Outlook 2016  Appendix 2015 Full-Year Results 33

  34. Slide 34: Divisional outlook 2016

    Divisional outlook 2016  Another year of good organic growth, supported by robust growth in Clinical Health Solutions and gradually improving trend in Health Learning, Research & Practice  Expect slight margin improvement as we continue to invest to drive growth  Expect underlying revenue growth

  35. Slide 35: Guidance 2016

    Guidance 2016 Performance indicators FY 2016 Guidance Adjusted operating profit margin 21.5%–22.0% Adjusted free cash flow €600-€625 million Return on invested capital > 9% Diluted adjusted EPS Mid-single-digit growth Guidance for adjusted free cash flow and diluted adjusted EPS is in constant curre

  36. Slide 36: Q&A

    Q&A

  37. Slide 37: Appendix

    Appendix

  38. Slide 38: Balance Sheet

    Balance Sheet (€ million, unless otherwise stated) Dec. 31, 2015 Dec. 31, 2014 Goodwill and intangible assets 5,550 5,172 Equity-accounted investees and financial assets 30 32 Other non-current assets 208 216 Non-current assets 5,788 5,420 Cash and cash equivalents 812 535 Other current assets 1,499

  39. Slide 39: Reconciliation: Adjusted net financing costs to financing results

    Reconciliation: Adjusted net financing costs to financing results (€ million) FY 2015 FY 2014 Adjusted net financing costs (119) (113) Loss on investment available-for-sale - (14) Employee benefits financing component (5) (5) Divestment related results on equity-accounted investees (1) 76 Financing

  40. Slide 40: Revenues by type

    Revenues by type (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG Digital and services subscriptions 2,561 2,155 +19% +6% +5% Print subscriptions 314 341 -8% -12% -9% Other recurring 326 281 +16% +1% +0% Recurring revenues 3,201 2,777 +15% +3% +3% Print books 299 289 +4% -6% -5% CLS transactional 278 215 +29

  41. Slide 41: Revenues by media format and type

    Revenues by media format and type FY 2015 Revenues Governance, Risk & Health Tax & Accounting Legal & Regulatory Compliance Services Print Print 6% 7% 2% Print 21% Digital: Services Services other 32% Print Digital 1% 16% Tax & 48% Digital 41% Accounting software 66% Digital 78% 71% Services 11% FS

  42. Slide 42: Debt maturity profile

    Debt maturity profile Debt Maturity Profile (€ million) 812 752 697 396 294 248 196 12 5 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 >2025 year-end Cash & cash equivalents Debt due in 2016 includes €285 million of bank overdrafts used for cash management purposes. Total cash and cash equi

  43. Slide 43: Former Tax & Accounting

    Former Tax & Accounting € million FY 2015 FY 2014 Δ Δ CC Δ OG Revenues 1,078 946 +14% +3% +3% Adjusted 295 250 +18% +6% +7% operating profit Margin 27.4% 26.4% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth Revenues by Media Format Revenues by Geographic Marke

  44. Slide 44: Former Financial & Compliance Services

    Former Financial & Compliance Services € million FY 2015 FY 2014 Δ Δ CC Δ OG Revenues 482 401 +20% +6% +6% Adjusted 90 65 +37% +21% +21% operating profit Margin 18.6% 16.3% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth F&CS Segments Revenues by Geographic Mar

  45. Slide 45: Former Legal & Regulatory

    Former Legal & Regulatory € million FY 2015 FY 2014 Δ Δ CC Δ OG Revenues 1,626 1,497 +9% 0% 0% Adjusted 320 305 +5% -8% -7% operating profit Margin 19.7% 20.3% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth L&R Segments Revenues by Geographic Market Corporate

Wolters Kluwer — FY2015 Earnings Presentation on 6ix